Meet the Right Audience

The pharmaceutical market in South Korea will rise from approximately $18.6 billion in 2016 to $20.4 billion in 2020, representing a compound annual growth rate (CAGR) of 2.4%. The Korean government is encouraging Research and Development (R&D) and sustaining growth initiatives in the pharmaceutical industry, such as the Korean Small Business Innovation Research program.

CPhI Korea - Event profile

Event Profile

CPhI Korea provides the ideal platform to gain insights and do business with decision makers in the regional market. The exhibition is a key opportunity for you to accomplish months of business over just a few days. With a high focus on the local market, the 2018 event saw participation of decision makers covering R&D, business development and sales and marketing.

Stand Out of the Crowd!

Maximize your company's exposure pre-during and post CPhI Korea 2019. To learn more about the additional promotional opportunities to drive traffic to your stand, increase brand awareness or generate more leads, download the official sponsorship brochure!

CPhI Korea - Promo Opportunities
CPhI Korea - Market ingo - growth
CPhI Korea - Market info - Biopharma
CPhI Korea - Market info - Exports

CPhI Korea was really helpful to establish marketing strategies in Korea through collecting Korean health ingredients market information from domestic exhibitors and buyers. Also, it was a good opportunity to meet many Korean companies who could be potential buyers.
- Edison Hsieh, Sales Manager of Contek Lifescience

Exhibitor Assistance

CPhI Korea - Promo Opportunities

Sales Brochure

Exhibitor FAQ

FAQ

Book a Stand

Book a Stand

Exhibitor Warning

Exhibitor Warning

DO NOT UNDER ANY CIRCUMSTANCES SIGN ANY FORMS FROM: 

  • Expo Guide
  • ExpoFairs
  • FairGuide.com
  • Construct Data Verlag
  • Tradeconference.info
  • Fair Express Ltd
  • GETA

These companies target exhibitors through legitimate exhibition guides. These publications have no connection with us or any of our events. We strongly advise our exhibitors, and the entire exhibition community, to be most vigilant against this and similar organisations.